The article explores the benefits and misconceptions of risk-based monitoring (RBM) in clinical trials, emphasizing its potential to improve trial efficiency and patient safety. It highlights how RBM helps balance critical data collection with patient burden, ensuring more effective oversight without sacrificing data quality. The piece also discusses the challenges of transitioning to RBM and the importance of managing change effectively across all stakeholders in the clinical trial process.
